The University of Colorado Boulder signs option agreement with Nanoly Bioscience for vaccine protection technology.

Life sciences startup Nanoly Bioscience has entered into an option agreement with the University of Colorado Boulder to develop a technique for delivering vaccines to rural and underdeveloped areas of the world.

Vaccines used to treat conditions such as measles, tetanus, polio and others have to be kept cool during transportation and storage – around the 2 – 8 degrees centigrade region – to avoid degradation. This can prove especially tricky in areas where electricity is in short supply.


Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?